Announcements Trials
Browse Landscape

Status

Completed 2704Recruiting 1053Unknown 996Terminated 900Active not recruiting 553Not yet recruiting 319Withdrawn 250Enrolling by invitation 27Suspended 21No longer available 13Approved for marketing 11Available 8Temporarily not available 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Expanded_access 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma, Ewing 1Prostatic Neoplasms, Castration-Resistant 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Myelodysplastic Syndromes 1Locally Advanced Pancreatic Adenocarcinoma 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1KRAS G12V Mutant Advanced Epithelial Cancers 1Hematologic Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

telisotuzumab vedotin 1Erlotinib Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Temporarily not available × Carcinoma, Non-Small-Cell Lung × Clear all
NCT04830202 2026-05-13

Expanded Access to Telisotuzumab Vedotin

AbbVie

Temporarily not available
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01297101 2011-02-16

Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy

Shanghai Chest Hospital

Temporarily not available
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡